ANGO

NEUTRALEarnings

AngioDynamics, Inc.

2026-09-28

Price

$15.54

+0.32%

This is the 2026-09-28 snapshot — the signals and analysis for ANGO as of this single trading day.

View full ANGO research hub →

Score9.0Priority

Signals4/8 DNA1/13 Act · 1/4 Risk

SentimentNEUTRALScore: 7

Volume1.1xvs 20d avg

Analysis

Institutional buyers are actively absorbing AngioDynamics (ANGO) shares ahead of its newly announced October 8 earnings, completely ignoring the loud US-Iran geopolitical noise. The stock is holding its structural trend, supported by PERFECT_STACK and SMA_BOUNCE signals, which perfectly aligns with the broader RISK_ON macro regime. With credit spreads remarkably tight at 0.81% and the VIX compressing, the market is pricing in robust liquidity rather than systemic fear. This bullish divergence between sensationalist headlines and resilient price action provides high conviction that the stock is gearing up for fundamental price discovery.

Fired Signals

STEADY CLIMBGOLDEN CROSSMARKET LEADERPERFECT STACKSMA BOUNCEDISTRIBUTION

Key Takeaways

Resilient price action amid geopolitical noise confirms institutional accumulation and a high-conviction bullish setup.
The newly announced October 8 earnings date serves as the primary structural catalyst, shifting focus to fundamental MedTech growth and the ongoing CEO transition.
Risk is well-defined against the $15.20 support level; a breakdown here invalidates the current technical structure.

← Back to 2026-09-28 View Full ANGO History →Yahoo Finance &nearr;